STOCK TITAN

MSP Recovery registers 56,896 shares for resale

(Neutral)
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

MSP Recovery, Inc. (MSPR) filed a prospectus supplement covering the potential resale by selling securityholders of up to 56,896 shares of Class A common stock. This includes 28,572 shares issuable upon exercise of low-priced VRM warrants, 2,858 issued shares and 14,286 warrant shares for VRP, and 11,180 shares issued to Palantir for products and services. The company would receive only nominal proceeds from warrant exercises at an exercise price of $0.0175 per share, and receives no proceeds from resale transactions.

The filing also attaches a Form 8-K describing new short-term funding arrangements. Hazel Partners Holdings LLC provided two discretionary advances of $0.03 million each under an existing working capital credit facility, and VRM MSP Recovery Partners, LLC provided two one-time advances of recovery proceeds of $0.03 million each, all primarily for operating expenses. The company states that these are standalone accommodations, the facility remains fully discretionary, and there is currently no additional committed or expected funding available under the facility or from VRM.

Positive

  • None.

Negative

  • None.

Filing Explained

MSP Recovery updated an existing registration covering up to 56,896 Class A shares for possible resale by selling securityholders. The filing reports no completed sale and states that the securities lack an active public trading market, so this disclosure concerns resale registration rather than issuer proceeds or a completed transaction.

Shares registered for resale 56,896 shares of Class A Common Stock Maximum number of shares offered by selling securityholders under this prospectus supplement
VRM Warrants shares issuable 28,572 shares of Class A Common Stock Shares issuable upon exercise of VRM Warrants issued under the Second Virage MTA Amendment
VRP consideration and warrant shares 2,858 issued shares and 14,286 warrant shares Shares issued to VRP and shares issuable upon exercise of the VRP Warrant
Palantir shares issued 11,180 shares of Class A Common Stock Shares issued to Palantir Technologies, Inc. as consideration for products and services
VRM and VRP Warrant exercise price $0.0175 per share Exercise price of the VRM Warrants and VRP Warrant, yielding only nominal proceeds if exercised
Hazel advances for operating expenses $0.03 million and $0.03 million Two one-time advances under the Working Capital Credit Facility funded on August 18 and 28, 2026
VRM recovery proceeds advances $0.03 million and $0.03 million Two one-time advances of recovery proceeds under VRM addenda funded on August 14 and 28, 2026
Prior Operational Collection Floor advances approximately $6.0 million Aggregate advances under the Operational Collection Floor as of the Q3-2025 Form 10-Q
Expert Market market
"Our Common Stock, Public Warrants and New Warrants are eligible for unsolicited quotations on the OTC Markets Group’s Expert Market"
An expert market is a trading venue or segment where a designated professional or market maker actively runs the buying and selling process for certain securities, especially those that are complex or thinly traded. Like an auctioneer at a niche market who knows the products and keeps transactions flowing, the expert helps set fair prices and provide liquidity; for investors this affects how easily they can trade, the transparency of prices, and potential costs or risks when buying or selling.
reverse stock split financial
"to effect a 1-for-7 reverse stock split of the Company’s common stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Operational Collection Floor financial
"includes a discretionary funding mechanism referred to as the Operational Collection Floor"
working capital credit facility financial
"the Company is party to a working capital credit facility with Hazel"
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

How many MSPR Class A shares are covered by this prospectus supplement?

The prospectus supplement covers the potential resale of 56,896 shares of MSP Recovery, Inc. Class A common stock by selling securityholders, including shares issued and shares issuable upon exercise of certain warrants held by VRM, VRP, and Palantir.

Does MSPR receive proceeds from the resale of the 56,896 shares?

MSP Recovery, Inc. does not receive proceeds from the resale of the 56,896 shares. It would receive only nominal proceeds if the VRM and VRP warrants are exercised, due to the low exercise price of $0.0175 per share.

What new funding did MSPR obtain from Hazel Partners Holdings LLC?

MSP Recovery, Inc., through subsidiaries, obtained two one-time advances of $0.03 million each from Hazel Partners Holdings LLC under a discretionary working capital credit facility, primarily for operating expenses. The company states no additional funding is currently available under this facility.

What advances did VRM MSP Recovery Partners, LLC provide to MSPR?

VRM MSP Recovery Partners, LLC agreed to two one-time advances of recovery proceeds of $0.03 million each, funded on August 14 and August 28, 2026, to be used only for operational expenses. The addenda do not obligate VRM to provide further advances.

Where is MSPR’s common stock currently quoted?

MSP Recovery, Inc.’s common stock, public warrants, and new warrants are eligible for unsolicited quotations on the OTC Markets Group’s Expert Market under symbols MSPR, MSPRZ, and MSPRW. Quotations on the Expert Market are not publicly available, and there is no active public trading market.

What reverse stock split has MSPR implemented?

Effective 11:59 PM EDT on September 1, 2025, MSP Recovery, Inc. implemented a 1-for-7 reverse stock split of its common stock. Share and per-share information in the prospectus supplement has been adjusted to reflect this reverse split.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-279958

 

PROSPECTUS SUPPLEMENT NO. 57

(to Prospectus dated October 4, 2024)

 

 

 

MSP RECOVERY, INC.

56,896 Shares of Class A Common Stock

 

 

 

This prospectus supplement no. 57 amends and supplements the prospectus dated October 4, 2024 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (No. 333-279958). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on August 31, 2026 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement.

 

This prospectus relates to the offer and sale from time to time by the selling securityholders named in this prospectus (the “Selling Securityholders”), or their permitted transferees, of up to 56,896 shares of our Class A Common Stock, par value $0.0001 per share, including: (i) up to 28,572 shares of our Class A Common Stock issuable upon exercise of warrants (the “VRM Warrants”) issued to Virage Recovery Master, LP (“VRM”) pursuant to the MTA Amendment No. 2 and Amendment to the Amended and Restated Security Agreement (the “Second Virage MTA Amendment”) dated November 13, 2023; (ii) 2,858 shares of our Class A Common Stock issued to Virage Recovery Participation LP (“VRP”) and up to 14,286 shares of our Class A Common Stock issuable upon exercise of a warrant issued to VRP (the “VRP Warrant”), in partial satisfaction of amounts owed by the Company pursuant to that certain Services Agreement dated May 20, 2022 between Virage Capital Management LP (“Virage”) and the Company; and (iii) 11,180 shares of our Class A Common Stock issued to Palantir Technologies, Inc. (“Palantir”) as consideration for certain products and services rendered by Palantir. As the exercise price of the VRM Warrants and the VRP Warrant is only $0.0175 per share, should the VRM Warrants or the VRP Warrant be exercised, we would only receive nominal proceeds therefrom.

 

Our Common Stock, Public Warrants and New Warrants are eligible for unsolicited quotations on the OTC Markets Group’s Expert Market under the symbols “MSPR,” “MSPRZ,” and “MSPRW,” respectively. Quotations for securities on the Expert Market are not publicly available, and our securities do not have an active public trading market. Accordingly, current closing prices for our Common Stock, Public Warrants, and New Warrants are not publicly available.

 

Effective at 11:59 PM EDT on September 1, 2025, the Company amended its Second Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware to effect a 1-for-7 reverse stock split of the Company’s common stock (the “Reverse Split”). Unless otherwise noted, the share and per share information in this Prospectus Supplement No. 57 have been adjusted to give effect to the Reverse Split.

 

Investing in our securities involves risks. Before you invest in our securities, please carefully read the information provided in the “Risk Factors” section beginning on page 9 of the Prospectus and any in any applicable prospectus supplement, and Item IA of our Annual Report on Form 10-K for the fiscal year ending December 31, 2024, filed with the SEC on April 16, 2025.

 

Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

 

 

 

The date of this prospectus supplement is August 31, 2026.

 

 

 

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 14, 2026

 

 

 

MSP Recovery, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39445   84-4117825

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

  

3525 NW 7th Street
Miami, Florida
 33125
(Address of principal executive offices) (Zip Code)

 

(305) 614-2222

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading Symbol(s)

 

Name of each exchange on which registered

Class A common stock, $0.0001 par value per share   MSPR   OTC Market Group, Inc.
         
Redeemable warrants, each lot of 4,375 warrants exercisable for one share of Class A common stock at an exercise price of $50,312.50 per share   MSPRW   OTC Market Group, Inc.
         
Redeemable warrants, each lot of 4,375 warrants exercisable for one share of Class A common stock at an exercise price of $0.4375 per share   MSPRZ   OTC Market Group, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement

 

Hazel Partners Holdings, LLC Fundings

 

On August 17, 2026, MSP Recovery, Inc. (the “Company”), through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC (“Hazel”), in its capacity as administrative agent and lender under the Company’s existing working capital credit facility (the “August 17, 2026 Letter Agreement”) to provide $0.03 million to be used primarily for operating expenses.

 

On August 26, 2026, the Company, through its subsidiaries, entered into a letter agreement with Hazel, in its capacity as administrative agent and lender under the Company’s existing working capital credit facility (the “August 26, 2026 Letter Agreement,” and collectively with the August 17, 2026 Letter Agreement, the “Hazel Letter Agreements”) to provide $0.03 million to be used primarily for operating expenses.

 

As previously disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (the “Q3-2025 Form 10-Q”), the Company is party to a working capital credit facility with Hazel (the “Working Capital Credit Facility”), which includes a discretionary funding mechanism referred to as the Operational Collection Floor. Advances under the Operational Collection Floor are made solely at Hazel’s discretion, are not subject to any commitment or minimum availability, and are conditioned on the satisfaction or waiver of applicable conditions under the governing credit documentation. The Working Capital Credit Facility does not provide the Company with committed liquidity, does not establish a borrowing base, and does not obligate Hazel to fund any amounts.

 

As of the filing of the Q3-2025 Form 10-Q, the Company disclosed that aggregate advances under the Operational Collection Floor had reached approximately $6.0 million, and that no remaining funding capacity was available under the facility at that time.

 

Pursuant to the Hazel Letter Agreements, Hazel has agreed, in its sole discretion, to make two one-time advances of $0.03 million and $0.03 million (the “Advances”), respectively, to increase the Operational Collection Floor beyond the previously disclosed level. The advances were funded on August 18, 2026 and August 28, 2026, respectively, subject to the conditions set forth in the Hazel Letter Agreements and the underlying credit agreement, including the absence of any event of default or default at the time of funding.

 

The Advances are standalone accommodations, and do not reinstate, replenish, or otherwise reopen availability under the Working Capital Credit Facility or the Operational Collection Floor. Other than these specific advances, no additional funding is currently available to the Company under the Working Capital Credit Facility, and the Company has no rights to, and no reasonable basis to expect, any further advances thereunder. The Hazel Letter Agreements do not modify the discretionary nature of the facility, do not create any commitment for future funding, and do not provide the Company with access to ongoing or recurring liquidity.

 

The Company cautions that the receipt of the Advances should not be viewed as indicative of Hazel’s willingness to provide future funding, the availability of additional liquidity, or the Company’s ability to meet its operating or debt service obligations beyond the funding of this specific amount.

 

The foregoing description of the Hazel Letter Agreements does not purport to be complete and are qualified in their entirety by reference to the Hazel Letter Agreements, copies of which are filed as exhibits to this Current Report on Form 8-K.

 

1

 

 

VRM MSP Recovery Partners, LLC Advances

 

On August 14, 2026, the Company entered into a letter agreement (the “Third Addendum”) with VRM MSP Recovery Partners, LLC (“VRM”), pursuant to which VRM agreed to make available a one-time advance of recovery proceeds of $0.03 million. The Third Addendum serves as an addendum to the letter agreement dated July 8, 2026, and all terms contained therein remain in full force and effect unless otherwise specifically stated in the Third Addendum.

 

On August 27, 2026, the Company entered into a letter agreement (the “Fourth Addendum,” and with the Third Addendum, the “VRM Addenda”) with VRM, pursuant to which VRM agreed to make available a one-time advance of recovery proceeds of $0.03 million. The Fourth Addendum serves as an addendum to the letter agreement dated July 8, 2026, and all terms contained therein remain in full force and effect unless otherwise specifically stated in the Fourth Addendum.

 

The Third Addendum was funded on August 14, 2026 and the Fourth Addendum was funded August 28, 2026. The advances described in the VRM Addenda are one-time advances to be used only for operational expenses, and do not imply any obligation of VRM to provide any further advances. VRM reserved all rights under the applicable limited liability company agreement and related documents.

 

The foregoing descriptions of the VRM Addenda do not purport to be complete, and are qualified in their entirety by reference to the full text of the VRM Addenda, which are filed as exhibits to this Current Report on Form 8-K.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

 

To the extent required by Item 2.03 of Form 8-K, the information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)Exhibits

 

Exhibit

Number

  Description
10.1   Hazel Letter Agreement dated August 17, 2026
10.2   Hazel Letter Agreement dated August 26, 2026
10.3   Amendment No. 3 to Second Amended and Restated Credit Agreement dated October 2, 2024 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on October 7, 2024)
10.4   Virage Letter Agreement dated August 14, 2026
10.5   Virage Letter Agreement dated August 27, 2026
104   Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MSP Recovery, Inc.
Dated: August 31, 2026  
  By:

/s/ Thomas Hawkins

  Name: Thomas Hawkins
  Title: Director and Member of the Special Committee

 

3